Thirty Madison and Talkspace join forces to expand mental health access for women
Talkspace will be the therapy partner for femtech brand Nurx and migraine treatment platform Cove
Read more...Z2Live is another step closer to launching its multiplayer gaming platform for the iPhone. Today, the Seattle-based company announced $3 million in new funding from Madrona Venture Group. The firm previously invested $1 million in seed financing to Z2Live.
Beyond the financing, Z2Live is also unveiling its multiplayer gaming platform as a preview for developers. Targeted for iPhone and iPod touch game developers, Z2Live is basically offering an easy way to implement social gaming features into their new applications without the expense of developers having to maintain their own servers. It also saves developers time since the multiplayer platform is already built. Z2Live'splatform supports a wide variety of games including turn-based, racing, role-playing and even first person shooters.
Although the SDK is offered free of charge, Z2Live does take a share of the games profits buy receiving a share of the multiplayer revenue. In the gaming space, this can mean anything from whether the developer charges for a subscription plan to charging for upgrades and add-ons. Z2Live argues it's much easier to grow a multiplayer gaming business than a one-time purchase gaming business.
With the quick rise of people adopting smartphones like the iPhone, Z2Live is in a very good position. As it is, The Entertainment Software Association recently reported that 62% of gamers are already playing live social games with friends and as digital cellular networks become more accessible, we'll probably see these numbers rise.
WIth a platform like this, gaming startups may have a chance in stepping up against well established, Zynga or SGN.
Here's a demo of the platform in action -
Talkspace will be the therapy partner for femtech brand Nurx and migraine treatment platform Cove
Read more...Midi is currently on track to serve about 100,000 patients this year, up from about 30,000 in 2023
Read more...Wheel clinicians will be able to prescribe Owlet's BabySat, which monitors oxygen and heart rate
Read more...